NZ630353A - Pyrazolopyrimidines and related heterocycles as ck2 inhibitors - Google Patents

Pyrazolopyrimidines and related heterocycles as ck2 inhibitors

Info

Publication number
NZ630353A
NZ630353A NZ630353A NZ63035310A NZ630353A NZ 630353 A NZ630353 A NZ 630353A NZ 630353 A NZ630353 A NZ 630353A NZ 63035310 A NZ63035310 A NZ 63035310A NZ 630353 A NZ630353 A NZ 630353A
Authority
NZ
New Zealand
Prior art keywords
pyrazolopyrimidines
compounds
inhibitors
kinase
related heterocycles
Prior art date
Application number
NZ630353A
Inventor
Fabrice Pierre
Mustapha Haddach
Joe A Tran
Collin F Regan
David M Ryckman
Suchitra Ravula
Nicholas B Raffaele
Original Assignee
Senhwa Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senhwa Biosciences Inc filed Critical Senhwa Biosciences Inc
Publication of NZ630353A publication Critical patent/NZ630353A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The disclosure provides pyrazolopyrimidines and related heterocyclic compounds that inhibit protein kinase Casein Kinase II (CK2) activity, and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase associated conditions including inflammation, pain, and certain immunological disorders, and have the following general formula (II) or (II’).
NZ630353A 2009-12-04 2010-11-15 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors NZ630353A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26680109P 2009-12-04 2009-12-04
US35416510P 2010-06-11 2010-06-11
NZ60102610 2010-11-15

Publications (1)

Publication Number Publication Date
NZ630353A true NZ630353A (en) 2016-06-24

Family

ID=56132531

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ630353A NZ630353A (en) 2009-12-04 2010-11-15 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors

Country Status (1)

Country Link
NZ (1) NZ630353A (en)

Similar Documents

Publication Publication Date Title
MX2011012369A (en) Pyrazolopyrimidines and related heterocycles as kinase inhibitors.
WO2012170827A3 (en) Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
BR112012013508A2 (en) pyrazolopyrimidines and related heterocycles as ck2 inhibitors
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
WO2012016133A3 (en) Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
EA201300052A1 (en) [1,8] NAPHTHYRID DERIVATIVES
MX2011012037A (en) Heteroaryl compounds as pikk inhibitors.
EA200970738A1 (en) AKT ACTIVITY INHIBITORS
MX2009013077A (en) 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors.
EA201591753A1 (en) 3-PYRIMIDIN-4-ILOXAZOLIDIN-2-ONE AS MUTANT IDH INHIBITORS
TN2014000255A1 (en) Disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitors
EA201290894A1 (en) AZETIDINE DERIVATIVES OF PIPERIDIN-4-ILA AS JAK1 INHIBITORS
IN2012DN03112A (en)
MX342509B (en) Substituted indazole derivatives active as kinase inhibitors.
UA100540C2 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
TW200801008A (en) Protein kinase inhibitors
MX2009012066A (en) Substituted imidazopyridazines as pi3k lipid kinase inhibitors.
CL2012003503A1 (en) Compounds derived from substituted morpholin pyrimidines, protein kinase atr inhibitors; Pharmaceutical composition, useful for the prevention or treatment of cancer tumors.
EA200900819A1 (en) QUINAZOLINS FOR INHIBITION OF PDK1
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
EA201300080A1 (en) DIPYRIDIL DERIVATIVES SUITABLE FOR THE TREATMENT OF KINASE-DISEASES
MX2008001538A (en) 2-aminoaryl pyridines as protein kinases inhibitors.
MX2008002104A (en) 1-acyldihydropyrazol derivatives.
EA201100334A1 (en) BICYCLIC DERIVATIVES OF TRIAZOLE FOR THE TREATMENT OF TUMORS
EA200801430A1 (en) TRIAZOLE DERIVATIVES

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 NOV 2017 BY CPA GLOBAL

Effective date: 20161021

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2018 BY CPA GLOBAL

Effective date: 20170929

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2019 BY CPA GLOBAL

Effective date: 20181004

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2020 BY CPA GLOBAL

Effective date: 20191003

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2021 BY CPA GLOBAL

Effective date: 20201001

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2022 BY CPA GLOBAL

Effective date: 20210930

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2023 BY CPA GLOBAL

Effective date: 20220930

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2024 BY CPA GLOBAL

Effective date: 20230928